Special Surgery 12. Benign Tumors of the Liver: Symptoms, Differential Diagnosis, Treatment

I. General Approach and Differential Diagnosis

Definition

Benign liver lesions are non-metastatic, non-invasive focal lesions of hepatic parenchyma or bile/vascular structures
Most are found incidentally on ultrasound, CT or MRI
Main exam lesions:

Simple and polycystic liver cysts
Parasitic / echinococcal cysts
Hepatic hemangioma
Focal nodular hyperplasia (FNH)
Hepatocellular adenoma (HCA)

Clinical Features

Usually asymptomatic
Symptoms occur with large size, bleeding, rupture, infection or compression
Possible symptoms:

Right upper quadrant discomfort
Upper abdominal pain
Fullness / early satiety
Nausea
Palpable mass or hepatomegaly if large

Acute pain + hypotension → think bleeding adenoma or ruptured lesion
Fever → infected cyst, abscess, cholangitis or hydatid complication
Jaundice is uncommon in benign liver tumors; suggests biliary compression or another diagnosis

Differential Diagnosis

Malignant liver tumors:

Hepatocellular carcinoma (HCC)
Intrahepatic cholangiocarcinoma
Liver metastases

Infectious/inflammatory lesions:

Pyogenic liver abscess
Amoebic abscess
Hydatid cyst

Benign lesions that mimic each other:

Hemangioma vs metastasis/HCC
FNH vs adenoma
Adenoma vs well-differentiated HCC
Simple cyst vs cystic metastasis / cystadenoma / hydatid cyst

Diagnostic Principles

History:

Known cancer
Cirrhosis or chronic viral hepatitis
Oral contraceptive use, anabolic steroids
Pregnancy plans
Travel/exposure to Echinococcus
Fever, weight loss, night sweats

Labs:

Liver enzymes usually normal in benign incidental lesions
AFP if HCC differential
CEA/CA 19-9 if metastatic or biliary/cystic neoplasm differential
Eosinophilia and Echinococcus serology if hydatid cyst suspected

Imaging:

Ultrasound as first detection tool
Contrast-enhanced ultrasound, multiphasic CT or MRI for characterization
MRI is often best for FNH and hepatocellular adenoma characterization

Biopsy:

Avoid biopsy of typical hemangioma because bleeding risk and imaging diagnosis is usually enough
Avoid puncture/biopsy of suspected hydatid cyst unless specialist plan because leakage/anaphylaxis risk
Consider biopsy only after MDT discussion if imaging remains indeterminate and result changes management

II. Cystic Lesions of the Liver

Non-Parasitic Cysts

Simple Liver Cyst

Congenital benign biliary cystic lesion
Thin wall, clear fluid, no communication with bile ducts
Usually incidental and asymptomatic
Ultrasound:

Anechoic
Thin wall
Posterior acoustic enhancement
No septa, solid component or mural nodule

Treatment:

No treatment if asymptomatic and typical
Symptomatic large cyst → laparoscopic fenestration / deroofing
Percutaneous aspiration alone has high recurrence
Aspiration + sclerotherapy can be used in selected simple cysts
Resection if cystic neoplasm cannot be excluded

Polycystic Liver Disease

Multiple hepatic cysts
Can be isolated or associated with autosomal dominant polycystic kidney disease
Liver function usually preserved despite massive hepatomegaly
Symptoms:

Abdominal distension
Early satiety
Pain, reflux, dyspnea from mass effect

Treatment:

Observation if asymptomatic
Aspiration/sclerotherapy for dominant symptomatic cyst
Laparoscopic/open fenestration for multiple superficial dominant cysts
Hepatic resection in selected localized massive disease with adequate remnant
Liver transplantation only for severe diffuse disease with disabling symptoms, malnutrition, portal hypertension or impaired function

Parasitic Cysts: Echinococcosis / Hydatid Cyst

Caused mainly by Echinococcus granulosus
Humans are accidental intermediate hosts
Liver is the most common organ involved
Risk: contact with dogs/sheep in endemic areas

Clinical Features

Often asymptomatic for years
RUQ pain/fullness
Hepatomegaly
Compression of bile ducts → jaundice/cholangitis
Rupture/leakage:

Allergic reaction or anaphylaxis
Peritoneal dissemination
Secondary infection

Diagnosis

Ultrasound: cyst membranes, daughter cysts, hydatid sand depending on stage
CT/MRI: size, anatomy, calcification, daughter cysts, relation to vessels/bile ducts
ELISA / serology supports diagnosis
Eosinophilia can occur but is not always present
Differentiate from simple cyst, abscess, cystic metastasis and biliary cystic neoplasm

Treatment

Depends on cyst stage, size, location and complications
Albendazole is preferred antihelminthic; mebendazole is alternative
PAIR in selected uncomplicated active cysts:

Puncture
Aspiration
Injection of scolicidal agent, e.g. hypertonic saline
Re-aspiration

Surgery:

Pericystectomy / cystectomy
Partial hepatectomy in selected peripheral lesions
Drainage and management of biliary communication if present

Precautions:

Avoid spillage
Protect operative field with scolicidal-soaked packs when appropriate
Perioperative albendazole to reduce recurrence/spillage risk

III. Solid Benign Liver Tumors

Hepatic Hemangioma

Definition

Most common benign liver tumor
Vascular malformation / tumor composed of blood-filled vascular spaces
More common in women
Often incidental

Clinical Features

Usually asymptomatic
Large hemangioma can cause:

RUQ discomfort
Fullness or early satiety
Compression symptoms

Rare complications:

Rupture/bleeding
Kasabach-Merritt syndrome: thrombocytopenia/coagulopathy in giant vascular lesion

Diagnosis

Ultrasound: often well-defined hyperechoic lesion in normal liver
Contrast CT/MRI/CEUS:

Peripheral nodular enhancement
Progressive centripetal fill-in

MRI is very useful for atypical lesions
Blood-pool scintigraphy is historical/selected for larger lesions
No biopsy if typical hemangioma

Differential Diagnosis

Liver metastases
Hepatocellular carcinoma
FNH
Hepatocellular adenoma
Angiosarcoma in rare atypical aggressive vascular lesion

Treatment

No treatment if asymptomatic and diagnosis is secure
No routine follow-up needed for typical small hemangioma in healthy liver
Surgery only if:

Clearly symptomatic from lesion
Rapidly enlarging
Complications: bleeding, compression, Kasabach-Merritt syndrome
Diagnosis remains uncertain after expert imaging/MDT review

Options: enucleation or liver resection; embolization in selected bleeding/high-risk cases

Focal Nodular Hyperplasia (FNH)

Definition and Pathogenesis

Benign hyperplastic hepatocyte nodule in otherwise normal liver
Thought to be response to arterial/vascular malformation
Second most common benign solid liver tumor
Female predominance, usually young/middle-aged women
No malignant transformation in typical FNH

Clinical Features

Usually asymptomatic
Occasional vague upper abdominal discomfort
Bleeding/rupture is very rare

Diagnosis

CT, MRI or contrast-enhanced ultrasound
Typical finding: central scar, especially in larger lesions
MRI has highest diagnostic performance
Typical contrast pattern:

Strong arterial enhancement
Isointense/isodense in portal venous phase
Central scar delayed enhancement
Hepatobiliary MRI contrast often shows uptake because functioning hepatocytes/bile ducts are present

Differential Diagnosis

Hepatocellular adenoma
Fibrolamellar HCC
Hypervascular metastasis
Hepatocellular carcinoma

Treatment

No treatment if asymptomatic and diagnosis is certain
Follow-up is usually not needed for typical FNH
Stopping oral contraceptives is not routinely required for typical FNH; association is much weaker than with adenoma
Surgery only if:

Symptoms clearly caused by FNH
Pedunculated/exophytic growing lesion in exceptional cases
Diagnosis remains uncertain after expert imaging

Hepatocellular Adenoma (HCA)

Definition

Rare benign epithelial tumor of hepatocytes
Clinically important because of bleeding/rupture and malignant transformation risk
More common in women, but more dangerous in men

Risk Factors

Oral contraceptives / estrogen exposure
Pregnancy
Anabolic steroids
Obesity and metabolic syndrome
Glycogen storage disease
Male sex increases malignant transformation risk

Subtypes / Risk Logic

HNF1A-inactivated adenoma:

Often steatotic
Lower malignant risk

Inflammatory adenoma:

Associated with obesity/metabolic syndrome
Can be symptomatic and inflammatory

Beta-catenin activated adenoma:

Highest malignant transformation risk
More common in men/anabolic steroid exposure

Clinical Features

Often asymptomatic
Upper abdominal pain
Intratumoral/intracapsular bleeding → acute pain
Rupture → hemoperitoneum and shock
Risk of rupture increases above 5 cm
Rare malignant transformation to HCC, especially beta-catenin mutation or male patient

Diagnosis

Multiphasic MRI is preferred
CT can show hypervascular lesion and bleeding
MRI may identify HNF1A-inactivated and inflammatory subtypes
Beta-catenin activation cannot be reliably excluded by imaging alone
Biopsy only after specialist MDT discussion if diagnosis/subtype remains uncertain

Differential Diagnosis

FNH
Well-differentiated HCC
Hypervascular metastasis
Hemangioma

Treatment

Stop oral contraceptives / anabolic steroids
Weight loss and metabolic risk correction
Women:

Observe about 6 months after lifestyle/hormonal change
Resect if lesion remains >= 5 cm or continues to grow
Lesions < 5 cm: imaging follow-up

Men:

Resection generally recommended regardless of size because malignant risk is higher

Resect proven beta-catenin activated adenoma
Bleeding adenoma:

Hemodynamically unstable → transarterial embolization first if available
Resect residual viable lesion later if indicated

Surgery also indicated for rupture, persistent symptoms, uncertain diagnosis or suspected malignant transformation

IV. Treatment Summary and Surgical Aspects

When Observation Is Enough

Typical asymptomatic simple cyst
Typical asymptomatic small hemangioma
Typical asymptomatic FNH
Small HCA in woman after risk-factor withdrawal, if stable and no high-risk features

When Surgery / Intervention Is Needed

Lesion	Main Indications	Treatment
Simple cyst	Symptoms, compression, uncertain cystic neoplasm	Fenestration/deroofing, aspiration + sclerotherapy selected, resection if uncertain
Polycystic liver	Severe mass effect, malnutrition, impaired function/portal HTN	Drainage/fenestration/resection selected; transplantation rarely
Hydatid cyst	Active/large/symptomatic/complicated cyst	Albendazole, PAIR selected, pericystectomy/resection/drainage
Hemangioma	Symptoms, growth, compression, bleeding, uncertain diagnosis	Enucleation/resection; embolization selected
FNH	Rare: symptoms clearly related or uncertain diagnosis	Resection only exceptional
Hepatocellular adenoma	Male, beta-catenin, >=5 cm, growth, bleeding, rupture, suspicion of HCC	Risk-factor withdrawal, resection, embolization for acute bleeding

Surgical Principles

Operate only after high-quality liver imaging and MDT review if diagnosis is uncertain
Preserve healthy liver parenchyma whenever possible
Assess relation to major vessels and bile ducts
Laparoscopic surgery possible for selected peripheral lesions
Open surgery preferred for complex central lesions or major resections
For hydatid cysts: prevent spillage and anaphylaxis
For hemangioma: avoid unnecessary biopsy and control bleeding risk

Exam Pearls

Hemangioma: most common benign liver tumor; no biopsy; no surgery if asymptomatic
FNH: central scar; no malignant transformation; no treatment if diagnosis certain
HCA: estrogen/steroid association; stop hormones; resect men, beta-catenin, >=5 cm or growing lesions
Simple cyst: treat only if symptomatic or uncertain
Hydatid cyst: think daughter cysts, ELISA/eosinophilia, albendazole, PAIR/surgery, anaphylaxis risk